S. Florentinus

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

Gerd‐Rüdiger Burmester, Alan Kivitz, H. Küpper et al. · Annals of the Rheumatic Diseases · 2014 · 228 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis

Daniel Aletaha, Jen‐Fue Maa, Su Chen et al. · Annals of the Rheumatic Diseases · 2019 · 58 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension

Edward Keystone, Ferdinand C. Breedveld, Désirée van der Heijde et al. · The Journal of Rheumatology · 2013 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission

Daniel Aletaha, Xin Wang, Sheng Zhong et al. · Seminars in Arthritis and Rheumatism · 2019 · 39 citations

Medicine, Clinical Sciences, Immunology +12

Is new drug prescribing in primary care specialist induced?

S. Florentinus, Eibert R. Heerdink, Liset van Dijk et al. · BMC Health Services Research · 2009 · 38 citations · Full text

Medicine, Family Medicine, Clinical Medicine +11